Sep 2
SCTX · Scribe Therapeutics, Inc. · Documents
$17.10
+0.90 (+5.56%)
At close · Nov 4
Return incl. dividend (before tax)
Going-concern doubt
— cleared Sep 2, 2026
The latest filing states the doubt was alleviated.
“Substantial doubt about our ability to continue as a going concern existed as of June 30, 2026 and was alleviated as a result of the completion of our initial public offering and concurrent private placement, which resulted in aggregate net proceeds of approximately $140.7 million.”View the 10-Q filed Sep 2, 2026
Market Cap
$320.27M
Shares
18.93M
Volume · Nov 4
204.81K
Avg daily vol (3M)
375.75K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →
2026
Sep 2
Quarterly report
10-Q
FY2026 Q2, ended Jun 30
Quarterly report for FY2026 Q2
AI summary on its way
Revenue $1.92M
▼ 60.8%
Net loss $6.48M
Diluted EPS -$2.62
Jul 27
Jul 20
Jul 10
Jul 2
Showing 1–6 of 6 documents